Oct. 25 at 3:54 PM
$ADMA Adam S. Grossman, President and CEO of ADMA Biologics, INC. (NASDAQ:ADMA), sold 21,000 shares of common stock on October 24, 2025, at a price of
$16.0, for a total of
$336,000. The transaction comes as ADMA maintains a strong financial position, with InvestingPro data showing impressive revenue growth of 44% and a healthy current ratio of 5.3x.
On the same day, Grossman also exercised options to acquire 15,000 shares of ADMA Biologics common stock at
$5.4, for a total value of
$81,000.